CRISPR-话题@MedSci

#CRISPR#

417篇内容 | 4480人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276140, encodeId=643b12e614004, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Carl Juno团队发表在Science上的新研究表明，CRISPR基因编辑后的T细胞在癌症患者中可存活数月, objectType=article, longId=187855, objectId=84d618e85550, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d618e85550, replyNumber=0, likeNumber=71, createdTime=2020-02-13, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d618e85550, moduleTitle=Carl Juno团队发表在Science上的新研究表明，CRISPR基因编辑后的T细胞在癌症患者中可存活数月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84d618e85550)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276139, encodeId=d98d12e61399d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, objectType=article, longId=185698, objectId=7e00185698b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e00185698b8, replyNumber=0, likeNumber=104, createdTime=2020-01-06, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e00185698b8, moduleTitle=Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e00185698b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276138, encodeId=731212e6138b4, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用, objectType=article, longId=185466, objectId=155d185466bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=155d185466bf, replyNumber=0, likeNumber=85, createdTime=2020-01-01, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=155d185466bf, moduleTitle=PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=155d185466bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276137, encodeId=ee3612e613757, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=新型CRISPR基因编辑技术可用于靶向扩增的抗生素抗性基因, objectType=article, longId=184905, objectId=8001184905bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8001184905bb, replyNumber=0, likeNumber=61, createdTime=2019-12-19, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8001184905bb, moduleTitle=新型CRISPR基因编辑技术可用于靶向扩增的抗生素抗性基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8001184905bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276136, encodeId=fa4912e61360d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应, objectType=article, longId=184737, objectId=5df1184e3771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5df1184e3771, replyNumber=0, likeNumber=62, createdTime=2019-12-15, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5df1184e3771, moduleTitle=Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5df1184e3771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276135, encodeId=7ade12e61354f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=如何利用CRISPR基因编辑技术改良机体白细胞来有效抵御癌症？, objectType=article, longId=184047, objectId=ddab18404e46, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddab18404e46, replyNumber=0, likeNumber=113, createdTime=2019-12-04, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddab18404e46, moduleTitle=如何利用CRISPR基因编辑技术改良机体白细胞来有效抵御癌症？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddab18404e46)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276134, encodeId=1b8812e613478, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=中科院发布《2019 研究前沿》，新型 CRISPR 和环状 RNA 入选, objectType=article, longId=183799, objectId=6044183e9908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6044183e9908, replyNumber=0, likeNumber=55, createdTime=2019-12-01, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6044183e9908, moduleTitle=中科院发布《2019 研究前沿》，新型 CRISPR 和环状 RNA 入选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6044183e9908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276133, encodeId=45b812e613365, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据, objectType=article, longId=183489, objectId=74b918348978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b918348978, replyNumber=0, likeNumber=77, createdTime=2019-11-25, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b918348978, moduleTitle=Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b918348978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276132, encodeId=576f12e61328f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=美国首例！CRISPR基因编辑技术应用于癌症治疗, objectType=article, longId=182673, objectId=e1171826e330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1171826e330, replyNumber=0, likeNumber=60, createdTime=2019-11-10, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1171826e330, moduleTitle=美国首例！CRISPR基因编辑技术应用于癌症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1171826e330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276131, encodeId=79ef12e61319a, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=主动撤回论文：CRISPR基因编辑婴儿可能会早逝的研究出现错误, objectType=article, longId=181494, objectId=e7c71814945b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7c71814945b, replyNumber=0, likeNumber=70, createdTime=2019-10-19, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7c71814945b, moduleTitle=主动撤回论文：CRISPR基因编辑婴儿可能会早逝的研究出现错误, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7c71814945b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276130, encodeId=c9df12e613000, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature Immunol | 发明基于CRISPR的集成内源基因激活肿瘤免疫疗法, objectType=article, longId=181371, objectId=da9f1813e1c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da9f1813e1c6, replyNumber=0, likeNumber=86, createdTime=2019-10-18, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da9f1813e1c6, moduleTitle=Nature Immunol | 发明基于CRISPR的集成内源基因激活肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da9f1813e1c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276129, encodeId=bcae12e6129e9, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Mol Cell:张锋再造三合一组合抗病毒的新型CRISPR Cas13系统, objectType=article, longId=181275, objectId=fe0d1812e584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe0d1812e584, replyNumber=0, likeNumber=64, createdTime=2019-10-17, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe0d1812e584, moduleTitle=Mol Cell:张锋再造三合一组合抗病毒的新型CRISPR Cas13系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe0d1812e584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276128, encodeId=8f4612e61284d, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=张锋再造三合一组合抗病毒的新型CRISPR Cas13系统, objectType=article, longId=181258, objectId=550f1812589a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=550f1812589a, replyNumber=0, likeNumber=58, createdTime=2019-10-17, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=550f1812589a, moduleTitle=张锋再造三合一组合抗病毒的新型CRISPR Cas13系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=550f1812589a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276127, encodeId=1c9412e6127bc, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Cell:首次发现针对III型CRISPR-Cas系统的蛋白抑制剂, objectType=article, longId=180679, objectId=2b5d1806e9cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b5d1806e9cc, replyNumber=0, likeNumber=71, createdTime=2019-10-10, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b5d1806e9cc, moduleTitle=Cell:首次发现针对III型CRISPR-Cas系统的蛋白抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b5d1806e9cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276126, encodeId=522e12e612630, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nat Biotech：媲美CRISPR-Cas9, 新CRISPR 工具探知90%的基因编辑领域, objectType=article, longId=180224, objectId=b4a818022443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4a818022443, replyNumber=0, likeNumber=78, createdTime=2019-09-30, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4a818022443, moduleTitle=Nat Biotech：媲美CRISPR-Cas9, 新CRISPR 工具探知90%的基因编辑领域, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4a818022443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276125, encodeId=420c12e61257f, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=美国将首次进行CRISPR人体临床研究, objectType=article, longId=178857, objectId=e9221e8857e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9221e8857e0, replyNumber=0, likeNumber=58, createdTime=2019-09-06, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9221e8857e0, moduleTitle=美国将首次进行CRISPR人体临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9221e8857e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276124, encodeId=e50512e61242a, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, objectType=article, longId=176793, objectId=62aa1e679336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62aa1e679336, replyNumber=0, likeNumber=72, createdTime=2019-08-05, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62aa1e679336, moduleTitle=SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62aa1e679336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276123, encodeId=3fb812e612335, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Nature：肌营养不良可咋整？CRISPR带来治疗新曙光, objectType=article, longId=176582, objectId=ab4b1e65826d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab4b1e65826d, replyNumber=0, likeNumber=73, createdTime=2019-08-02, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab4b1e65826d, moduleTitle=Nature：肌营养不良可咋整？CRISPR带来治疗新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab4b1e65826d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276122, encodeId=e2be12e6122be, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=Science：张锋团队免费开源给学术研究！升级版CRISPR拓展RNA功能编辑, objectType=article, longId=175376, objectId=67a61e5376af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67a61e5376af, replyNumber=0, likeNumber=65, createdTime=2019-07-15, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67a61e5376af, moduleTitle=Science：张锋团队免费开源给学术研究！升级版CRISPR拓展RNA功能编辑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67a61e5376af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276121, encodeId=803512e612125, content=<a href='/topic/show?id=755d5211a0' target=_blank style='color:#2F92EE;'>#CRISPR#</a>, objectTitle=“CRISPR婴儿”计划疯狂重启，顶尖科学家们表示无力阻止, objectType=article, longId=172271, objectId=5ae71e2271e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae71e2271e8, replyNumber=0, likeNumber=62, createdTime=2019-06-28, rootId=0, userName=yuandd, userId=583c133, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae71e2271e8, moduleTitle=“CRISPR婴儿”计划疯狂重启，顶尖科学家们表示无力阻止, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ae71e2271e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CRISPR

2020-05-29

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Carl Juno团队发表在Science上的新研究表明，CRISPR基因编辑后的T细胞在癌症患者中可存活数月

2020-02-13

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Circulation：CRISPR/Cas9基因编辑或可用于治疗LDLR突变型家族性高胆固醇血症

2020-01-06

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

PNAS：探究“致命”肺癌，科学家发现CRISPR-Cas9系统新应用

2020-01-01

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

新型CRISPR基因编辑技术可用于靶向扩增的抗生素抗性基因

2019-12-19

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Commun：研究发现CRISPR-Cas9基因编辑系统在灵长类中不会导致明显的脱靶效应

2019-12-15

zhaojie88 (审核中...)

前往app查看评论内容

#CRISPR#

如何利用CRISPR基因编辑技术改良机体白细胞来有效抵御癌症？

2019-12-04

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

中科院发布《2019 研究前沿》，新型 CRISPR 和环状 RNA 入选

2019-12-01

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Vertex揭示了在首批接受CRISPR/Cas9基因编辑疗法患者中激动人心的数据

2019-11-25

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

美国首例！CRISPR基因编辑技术应用于癌症治疗

2019-11-10

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

主动撤回论文：CRISPR基因编辑婴儿可能会早逝的研究出现错误

2019-10-19

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature Immunol | 发明基于CRISPR的集成内源基因激活肿瘤免疫疗法

2019-10-18

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Mol Cell:张锋再造三合一组合抗病毒的新型CRISPR Cas13系统

2019-10-17

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

张锋再造三合一组合抗病毒的新型CRISPR Cas13系统

2019-10-17

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Cell:首次发现针对III型CRISPR-Cas系统的蛋白抑制剂

2019-10-10

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nat Biotech：媲美CRISPR-Cas9, 新CRISPR 工具探知90%的基因编辑领域

2019-09-30

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

美国将首次进行CRISPR人体临床研究

2019-09-06

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

SCI TRANS MED：CRISPR-Cas9编辑造血干细胞，助力治疗相关移植

2019-08-05

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Nature：肌营养不良可咋整？CRISPR带来治疗新曙光

2019-08-02

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

Science：张锋团队免费开源给学术研究！升级版CRISPR拓展RNA功能编辑

2019-07-15

yuandd (审核中...)

前往app查看评论内容

#CRISPR#

“CRISPR婴儿”计划疯狂重启，顶尖科学家们表示无力阻止

2019-06-28

科室
- - 订阅+
  - 更多科室
工具
服务